ICL Spanish Study Group –Opacities G0 (3%, only 0.6% clinically significant) –Opacities G1 (4.4%, only 1.7% clinically significant) –Over/undersizing secondary interventions 12 G0 versus 16 in G1 –Explanted 9 in G0 versus 27 in G1